The 2-Minute Rule for Risdiplam
Risdiplam is the only real orally administered drug accredited for the cure of SMA. It was FDA approved in 2020 to be used in patients two months of age and more mature, and it functions as an SMN2 gene splicing modifier bringing about greater levels of SMN protein. Oral administration is a big advantage of this drug as it can influence systemic ti